Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity.

The risk of anxiety and depression in MASLD is not different from that generated by diabetes and obesity per se. MASLD patients do not perceive liver disease as a specific source of psychological distress, possibly as a consequence of the unawareness of progressive liver disease.